FDA to Approve Pfizer/BioNTech Covid-19 Vaccine for Children Ages 12 to 15
The US Food and Drug Administration is set to approve Pfizer/BioNTech's Covid-19 vaccine for children ages 12 to 15 next week, based on a report stating that the FDA is reviewing scientific data provided by Pfizer. This comes as another American pharma firm, Moderna, is also testing vaccines in children as young as six months. The announcement of approval follows a Phase 3 trial of Pfizer's BNT162b2 vaccine, which demonstrated 100 percent efficacy and robust antibody responses among 12 to 15-year-olds.
Key Takeaways:
- The FDA is reviewing scientific data from Pfizer on its Covid-19 vaccine for children ages 12 to 15.
- The vaccine, BNT162b2, demonstrated 100 percent efficacy and robust antibody responses in a Phase 3 trial involving 2,260 adolescents.
- Moderna is also testing vaccines in children as young as six months, with plans to ask the FDA for approval in infants and children later this year.
- Almost 313 million doses of the Covid-19 vaccine have been distributed in the US, with 247 million administered as of Monday.
- 105.5 million people, or 31.8 percent of the population, have received two doses of the vaccine, according to the US Centers for Disease Control and Prevention (CDC).
- Over 32 million cases and more than 577,000 deaths have been recorded in the US since the start of the pandemic.
- Global cases stand at 153.5 million, with over 3.2 million fatalities.
Statistics:
- 313 million doses of the Covid-19 vaccine have been distributed in the US.
- 247 million doses of the vaccine have been administered as of Monday.
- 105.5 million people have received two doses of the vaccine, representing 31.8 percent of the US population.
- There have been over 32 million cases of Covid-19 in the US since the start of the pandemic.
- More than 577,000 deaths have been recorded in the US due to Covid-19.
- Global cases stand at 153.5 million.
- Over 3.2 million fatalities have been reported worldwide due to Covid-19.
Sources:
- CNN
- Philippines News Agency
- Johns Hopkins University
- US Centers for Disease Control and Prevention (CDC)
- Pfizer
- BioNTech